Most Recent
The developer of the blockbuster horror video game Dead by Daylight has succeeded in revoking the trade mark of rival developer of a virtual sporting game.
A founder and former principal at a Sydney intellectual property firm has made the switch to Dentons, filling out the firm's Australasian patents team.
Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug.
The developer of a Canola seed hybrid tolerant to herbicide has lost a bid for seed grower Nuseed to relabel its products, which are already stocked in 361 retail locations.
Sydney hospitality mogul Justin Hemmes has prevailed in a trade mark stoush with Brisbane restaurant Establishment 203.
Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.
Cosmetics maker Self Care has won its case against companies with ties to China that were found to have sold counterfeit versions of its popular Freezeframe anti-ageing creams.
The Pakistani government's opposition to India's attempt to register a composite 'Basmati' trade mark will go on despite filing delays, with a delegate finding it was in the public interest to allow the opposition.
A former employee of internet service provider Broadband Solutions has been slapped with an injunction restraining his use of company materials and engagement with competitors, with a judge finding it is likely he breached confidentiality clauses.
CBA-backed climate venture capital firm Wollemi says that Tesla CEO Robyn Denholm did not use ‘Wollemi’ and ‘Wollemi Capital’ as trade marks “at any point in time”, as it seeks to defeat Denholm’s appeal of a decision which rejected her family office’s opposition to registration of the marks.